The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients

Summary

This study aims to confirm that SHR20004 is more effective than placebo in controlling blood glucose in patients with type 2 diabetes. Evaluate the efficacy, safety, and pharmacokinetics of SHR20004 after 24 weeks of treatment.

Timeline

Start

2024-10-25

Primary completion

2025-05-28

Completion

2025-09-30

Drugs

Indications